CIK 0001613103
- Large accelerated filer
Medtronic plc
Sign in to watch- Ticker
- MDT
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Apr 24
- Entity type
- Operating
- Phone
- +353 14381700
- Business address
- BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY, Ireland, H91 4K49
- Former names
- Medtronic Ltd, Medtronic Holdings Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,889,203
- in 3 filings, $5.8M under 10b5-1 plans
Net −$5,889,203. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-31 | Salmon Sean EVP & President Cardiovascular | Grant or award · Performance Share Units | +21,214 | 21,214 | ||
| 2023-07-31 | Salmon Sean EVP & President Cardiovascular | Grant or award · Stock Option (Right to Buy) | +68,196 | 68,196 | ||
| 2023-07-31 | Marinaro Michael EVP & President, Surgical OU | Grant or award | +6,837 | 29,890 | ||
| 2023-07-31 | Marinaro Michael EVP & President, Surgical OU | Grant or award · Performance Share Units | +17,093 | 17,093 | ||
| 2023-07-31 | Marinaro Michael EVP & President, Surgical OU | Grant or award · Stock Option (Right to Buy) | +48,139 | 48,139 | ||
| 2023-07-31 | Fong Ivan K EVP GENERAL COUNSEL & SECR | Grant or award | +7,977 | 40,807 | ||
| 2023-07-31 | Fong Ivan K EVP GENERAL COUNSEL & SECR | Grant or award · Performance Share Units | +19,941 | 19,941 | ||
| 2023-07-31 | Fong Ivan K EVP GENERAL COUNSEL & SECR | Grant or award · Stock Option (Right to Buy) | +56,162 | 56,162 | ||
| 2023-07-31 | PARKHILL KAREN L EVP & Chief Financial Officer | Grant or award | +12,535 | 44,418 | ||
| 2023-07-31 | PARKHILL KAREN L EVP & Chief Financial Officer | Grant or award · Performance Share Units | +31,336 | 31,336 | ||
| 2023-07-31 | PARKHILL KAREN L EVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +88,254 | 88,254 | ||
| 2023-07-31 | Martha Geoffrey Chairman and CEO | Grant or award | +34,185 | 139,097 | ||
| 2023-07-31 | Martha Geoffrey Chairman and CEO | Grant or award · Performance Share Units | +85,461 | 85,461 | ||
| 2023-07-31 | Martha Geoffrey Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +240,691 | 481,382 | ||
| 2023-07-14 | Wall Brett A. EVP & Pres Neuroscience | Sale 10b5-1 | −2,000 | $87.97 | $176K | 23,948 |
| 2023-07-10 | TEN HOEDT ROB EVP and Pres. Global Regions | Option exercise | +1,808 | $55.32 | $100K | 45,610 |
| 2023-07-10 | TEN HOEDT ROB EVP and Pres. Global Regions | Sale | −1,808 | $86.59 | $157K | 43,802 |
| 2023-07-10 | TEN HOEDT ROB EVP and Pres. Global Regions | Option exercise | +3,706 | $55.32 | $205K | 47,508 |
| 2023-07-10 | TEN HOEDT ROB EVP and Pres. Global Regions | Sale | −3,706 | $86.58 | $321K | 43,802 |
| 2023-07-10 | TEN HOEDT ROB EVP and Pres. Global Regions | Option exercise · Stock Option (Right to Buy) | −1,808 | 3,706 |
Page 21 of 24 · 474 trades